MYBL2 and glioma: Subsequently, we evaluated the prognostic accuracy of CCNB2, CDC20 and MYBL2 by calculating the time‐dependent ROC, AUC (area under the ROC curve) for one‐, three‐ and five‐year survival in glioma patients.